Klaus P Ebmeier Selected Research

Klaus P Ebmeier Research Topics

Disease

13	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 07/2004
8	Dementia (Dementias) 01/2021 - 11/2010
6	Cognitive Dysfunction 01/2022 - 01/2010
4	Schizophrenia (Dementia Praecox) 05/2014 - 06/2004
3	Major Depressive Disorder (Major Depressive Disorders) 10/2015 - 08/2008
2	Hypertension (High Blood Pressure) 01/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Stroke (Strokes) 01/2017 - 08/2012
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 08/2012
2	Depressive Disorder (Melancholia) 04/2016 - 05/2014
2	Disease Progression 09/2014 - 05/2011
2	Hallucinations (Hallucination) 01/2011 - 06/2004
2	Mood Disorders (Mood Disorder) 01/2011 - 11/2009
1	Alcoholism (Alcohol Abuse) 01/2022
1	Sleep Deprivation 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Abdominal Obesity 01/2017
1	Necrosis 10/2015
1	Hypothyroidism 05/2014
1	Parkinsonian Disorders (Parkinsonism) 02/2013
1	Vascular Diseases (Vascular Disease) 08/2012
1	Vascular Depression 07/2012
1	Diabetes Mellitus 11/2011
1	Hyperglycemia 11/2011
1	Psychotic Disorders (Schizoaffective Disorder) 05/2011
1	Parkinson Disease (Parkinson's Disease) 01/2011
1	Weight Gain 05/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2010
1	Confusion (Bewilderment) 08/2008
1	Seizures (Absence Seizure) 08/2008

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2010
6	Apolipoproteins E (ApoE)IBA 06/2015 - 01/2010
3	Apolipoprotein E4IBA 01/2021 - 02/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 05/2010
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2013 - 02/2010
2	CholesterolIBA 01/2021 - 01/2019
2	HDL CholesterolIBA 01/2019 - 01/2017
2	LipidsIBA 01/2017 - 05/2010
2	C-Reactive ProteinIBA 04/2016 - 10/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 05/2014 - 01/2010
2	LigandsIBA 11/2010 - 04/2008
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2010 - 04/2008
2	salicylhydroxamic acid (SHAM)IBA 01/2006 - 06/2004
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	IronIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017
1	HDL LipoproteinsIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Protons (Proton)IBA 01/2017
1	CytokinesIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	InterleukinsIBA 10/2015
1	ApolipoproteinsIBA 09/2014
1	Antipsychotic Agents (Antipsychotics)IBA 05/2014
1	Memantine (Namenda)FDA Link 01/2013
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2013
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2013
1	Donepezil (Aricept)FDA LinkGeneric 01/2013
1	Indicators and Reagents (Reagents)IBA 08/2012
1	GlucocorticoidsIBA 07/2012
1	Antidepressive Agents (Antidepressants)IBA 11/2011
1	antineoplaston A10 (A 10)IBA 05/2011
1	Levodopa (L Dopa)FDA LinkGeneric 01/2011
1	Cholinergic Agents (Cholinergics)IBA 11/2010
1	Amyloid beta-PeptidesIBA 02/2010
1	Genetic Markers (Genetic Marker)IBA 02/2010
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2010
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2010
1	AntioxidantsIBA 01/2010
1	Dehydroepiandrosterone (DHEA)IBA 01/2010
1	Vitamin B 6IBA 01/2010
1	Procaine (Novocaine)FDA LinkGeneric 01/2010
1	VitaminsIBA 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	ElementsIBA 11/2009
1	Prednisolone (Predate)FDA LinkGeneric 09/2006
1	AminesIBA 07/2004
1	OximesIBA 07/2004

Therapy/Procedure

3	Transcranial Magnetic Stimulation 01/2011 - 06/2004
2	Activities of Daily Living (ADL) 01/2014 - 01/2013
2	Therapeutics 02/2010 - 08/2008
1	Music Therapy 04/2014
1	Massage (Zone Therapy) 04/2014
1	Aromatherapy 04/2014
1	Secondary Prevention 01/2013
1	Hearing Aids (Hearing Aid) 01/2011